Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
68
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. RAPT Therapeutics Inc market cap is $1.61B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. RAPT Therapeutics Inc 52 week high is $58.02 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. RAPT Therapeutics Inc 52 week low is $5.67 as of November 21, 2026.
RAPT Therapeutics Inc stock price today is $58.02.
RAPT Therapeutics Inc stock price yesterday was $57.98.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. RAPT Therapeutics Inc's P/E ratio is -5.24.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. RAPT Therapeutics Inc P/B ratio is 6.4348.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. RAPT Therapeutics Inc 50-day moving average is $51.33.